SCOR SE (SCR) Fair Value & Analysis
Financial Services · FR · Market cap €5.8B · ISIN FR0010411983
What is SCOR SE really worth?
A solid business, trading 22% below our fair value of €43.22.
Strengths
Risks
Fair value as of: Aug 29, 2026
From 6 valuation models · updated 6 days ago
Share price −0.5% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- Solid quality (66/100) at a price below fair value, the discount is the argument here, not the business quality.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 29, 2026.
How to read this chart
60‑month range €10.70 – €34.68 · fair‑value band €32.41 – €54.02 · the €33.90 price screens below the €43.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 29, 2026.
Analysis
SCOR SE (SCR) currently trades at €33.90, while our model-based Fair Value estimate is €43.22, implying the stock looks roughly 21.6% undervalued today. The Quality Score stands at 66/100 (solid quality), in the Financial Services sector. Bull case: the Economic Profit group reads highest at a median of €38.63 per share, and 3 of the 6 models we run sit above the €33.90 price. Bear case: the Asset-Based group reads lowest at €16.60, and 3 of the 6 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, SCOR SE generated revenue of €15.5B at a net margin of 5.7%. Revenue declined 6.5% year over year. It earns a return on equity of 13.2%. Net debt stands at €1.7B. Fundamentals as of Aug 29, 2026
Our scenario range runs from €32.41 (bear case) to €54.02 (bull case); at €33.90, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 43% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 53% fair-value upside, at 27%, SCR screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly €3.17 per share, which is 7.3 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 6 models by family
Widest divergence: Economic Profit (€38.63) versus Asset-Based (€16.60). Highest evidence: Gordon GGM (67).
Notify me when SCR reaches fair value
Put SCR on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 29, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 78
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and the Asia Pacific. It operates in two segments, SCOR P&C and SCOR L&H.
Full company description
SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and the Asia Pacific. It operates in two segments, SCOR P&C and SCOR L&H. The SCOR P&C segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, cyber agricultural risks, and binders and facilities; It also provides business solutions including corporate risk insurance, as well as specialist lines, such as Political and Credit risk and Environmental Liability; and binders and facilities. The SCOR L&H segment provides life reinsurance products, such as protection for mortality, morbidity, behavioral risks, disability, long-term care, critical illness, medical, and personal accident. This segment also provides financial solutions that combine traditional life reinsurance with financial components and provide liquidity, balance sheet, solvency, and income improvements to clients; and longevity solutions that include products covering the risk of negative deviation from expected results due to the insured or annuitant living longer than assumed in the pricing of insurance covers provided by insurers or pension funds. The company is involved in the asset management business. SCOR SE was incorporated in 1956 and is headquartered in Paris, France.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
SCOR SE reported revenue of €16.2B in FY2025 versus €16.0B in FY2021, a compound +0.4%/yr. Reported net income was €851M in FY2025, compounding +16.9%/yr from FY2021.
of which total revenue +2.9 % · buybacks/dilution +0.5 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
Watch SCR: get an alert when its fair value changes →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- SCOR SE (SCRYY) (Q2 2026) Earnings Call Highlights: Strong Net Income and Solvency Ratio Amid ...
- SCOR announces the availability of its 2026 Interim Financial Report
- Japan Post Insurance and SCOR sign MOU Regarding the Ceding (Retrocession) of “Postal Life Insurance Policies” and Investment in a Reinsuran
- SCOR acknowledges the arbitration award confirming the validity of the retrocession treaties entered into with Covéa in June 2021
Peer Group
Insurance - Reinsurance · 29 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Insurance - Reinsurance median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Insurance - Reinsurance stocks, each showing price versus our Fair Value estimate (as of Aug 29, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| MUV2 MUV2 | €518.00 | €460.14 | −11% |
| Swiss Re AG SREN | CHF 141.15 | CHF 137.55 | −3% |
| Hannover Rück SE HNR1 | €258.20 | €216.20 | −16% |
| Reinsurance Group RGA | $246.02 | $261.04 | +6% |
| Everest Group EG | $370.06 | $507.47 | +37% |
| RenaissanceRe Holdings RNR | $330.41 | $563.91 | +71% |
| General Insurance Corporation GICRE | ₹355.85 | ₹594.47 | +67% |
| China Reinsurance (Group) Corporation 1508 | HK$1.22 | HK$2.43 | +100% |
| Hamilton Insurance Group HG | $35.35 | $54.04 | +53% |
| SiriusPoint Ltd SPNT | $23.98 | $37.12 | +55% |
Compare SCOR SE with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is SCOR SE (SCR) overvalued or undervalued?
What is the fair value of SCR?
What is the quality score of SCR?
What is the revenue of SCOR SE (SCR)?
What is the net profit margin of SCR?
Does SCOR SE pay a dividend?
Watch SCOR SE in the live analysis
One click puts SCOR SE on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.